Brief: PW Medtech Group Sees Decrease In HY Revenue From Group's Infusion Set Business In Range Of 35% To 45%
06/07/2020 12:14
July 6 (Reuters) - PW Medtech Group Ltd 1358.HK :
* SEES DECREASE IN REVENUE FROM GROUP'S INFUSION SET
BUSINESS FOR
6 MONTHS IN RANGE OF 35% TO 45%
* EXPECTED DECREASE IN REVENUE DUE TO OUTBREAK OF NOVEL
CORONAVIRUS
Source text for Eikon: urn:newsml:reuters.com:*:nHKS9wWjYD
Further company coverage: 1358.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PW Medtech
See all newsBrief: Pw Medtech Group Proposes Delisting Of Sichuan Ruijian Medical
Brief: PW Medtech Group Sees Net Profit For Six Months Ended June 30, 2026
Brief: PW Medtech Announces Deemed Acquisition Of Stake In Sichuan Ruijian Medical
Brief: Pw Medtech Posts FY Revenue RMB 823.5 Million
Brief: Pw Medtech Says Termination Of Subsequent Listing Of Sichuan Ruijian Medical